The diagnosis screening segment dominated the market for mammography workstations and accounted for the largest revenue share of around 39.0% in 2019. The high market share of this segment is primarily due to the high usage of mammography workstations in diagnostic screening. Diagnostic screening is performed on asymptomatic women to identify breast cancer at an early curable stage. Furthermore, an increasing number of breast screening programs is boosting the market growth. For instance, BreastScreen Australia is a national breast cancer screening program that invites women aged more than 50 years for a free mammography every two years.
The advance imaging segment is expected to grow at a lucrative growth rate during the forecast period. The high growth rate of the segment is primarily attributed to the high adoption of these devices and innovative product launches. For instance, in November 2019, Candelis, Inc launched an advanced breast imaging workstation. The device provides support for 3D breast ultrasound images and it is acquired by Hitachi, Siemens Acuson ABVS, GE Invenia ABUS, and iVu Sophia with a diagnostic tool for interpretation and reading.
North America dominated the market for mammography workstations in 2019 and accounted for a revenue share of 48.2% and is expected to maintain its dominance over the forecast period. Regionally, the market for mammography workstations is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The rising geriatric population and an increasing number of product launches are boosting the mammography workstation market in North America. Continuous technological advancement in the field of mammography and speedy FDA approvals is also contributing to the growth in the region. In addition, the presence of major players in the industry is further augmenting the growth of the market in the region.
In Asia Pacific, the market is anticipated to witness the fastest growth rate during the forecast period. The rising geriatric population and increasing awareness about early detection of breast cancer are the major factors contributing to market growth. Breast cancer in the Asia Pacific region is lower than its western counterpart. However, there has been a substantial rise in the incidence among the Asian population. Approximately, 24.0% of all breast cancer cases occur in the region, with the majority of those occurring in China and Japan. Furthermore, increasing government funding related to mammography and continuous technological development is boosting the market growth.
Leave a Reply